patient gets worse on coramsine, page-3

I dont think we should rush to conclusions here. This was not a clinical trial and cancer drugs rarely work on everyone. If it fails to improve only one person it means little, but a response on an advanvced patient would speak volumes. Better to wait for the report from Dr Nagourney. Many cancer drugs make it to market on a few months improvement over current treatments. There is much more anecdotal evidence coramsine works, PLUS a real clinical trial has verified it. Still waiting on a Phase 2.
I must admit I am surprised there was no response, because Dr Nagourneys assay methods have been shown to be a very accurate predictor of drug efficacy on a particular patient.